VIDEO: PALADIN looks at long-term real-world results of Iluvien

ByChristopher D Riemann, MD

ByDavid W. Mullin

Fact checked byChristine Klimanskis, ELS

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

NEW YORK — In this Healio Video Perspective from the ASRS meeting, Christopher D. Riemann, MD, discusses phase 4 data from the PALADIN study assessing Alimera’s Iluvien implant for diabetic macular edema.

Published by:

Sources/Disclosures

Collapse

Source:

Healio Interviews

Disclosures: Riemann reports being a paid consultant for Alimera Sciences.

Read more about

diabetic macular edema

intraocular pressure

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment